neuro bciNew
Merge Labs
Ultrasound-based non-invasive brain interface
weight 0.0Flux 62▴PaidLaunched 2026-06
💸 No earnings reported yet
What it is
Sam Altman-backed BCI startup developing non-surgical ultrasound brain interfaces enhanced by gene therapy to read and stimulate deep neural activity. Raising ~$250M at ~$850M valuation.
How AI plugs in
AI decoders interpret ultrasound-read neural activity for high-bandwidth interfacing.
★ Reviews
No reviews yet — be the first.Your rating